Biomedical Engineering Reference
In-Depth Information
96. Kimura, I., Konishi, M., Asaki, T., Furukawa, N., Ukai, K., Mori, M., Hirasawa, A.,
Tsujimoto, G., Ohta, M., Itoh, N., Fujimoto, M.: Neudesin, an extracellular heme-binding
protein, suppresses adipogenesis in 3T3-L1 cells via the MAPK cascade. Biochem. Biophys.
Res. Commun. 381, 75-80 (2009)
97. Shimba, S., Wada, T., Tezuka, M.: Arylhydrocarbon receptor (AhR) is involved in negative
regulation of adipose differentiation in 3T3-L1 cells: AhR inhibits adipose differentiation
independently of dioxin. J. Cell Sci. 114, 2809-2817 (2001)
98. Ueno, T., Fujimori, K.: Novel suppression mechanism operating in early phase of
adipogenesis by positive feedback loop for enhancement of cyclooxygenase-2 expression
through prostaglandin F2a receptor mediated activation of MEK/ERK-CREB cascade.
FEBS J. 278, 2901-2912 (2011)
99. Tang, Q.Q., Gronborg, M., Huang, H., Kim, J.W., Otto, T.C., Pandey, A., Lane, M.D.:
Sequential phosphorylation of CCAAT enhancer-binding protein b by MAPK and glycogen
synthase kinase 3b is required for adipogenesis. Proc. Natl. Acad. Sci. USA 102, 9766-9771
(2005)
100. Adams, M., Reginato, M.J., Shao, D., Lazar, M.A., Chatterjee, V.K.: Transcriptional
activation by peroxisome proliferator-activated receptor c is inhibited by phosphorylation at
a consensus mitogen-activated protein kinase site. J. Biol. Chem. 272, 5128-5132 (1997)
101. Camp, H.S., Tafuri, S.R.: Regulation of peroxisome proliferator-activated receptor c activity
by mitogen-activated protein kinase. J. Biol. Chem. 272, 10811-10816 (1997)
102. Chan, G.K., Deckelbaum, R.A., Bolivar, I., Goltzman, D., Karaplis, A.C.: PTHrP inhibits
adipocyte differentiation by down-regulating PPAR c activity via a MAPK-dependent
pathway. Endocrinology 142, 4900-4909 (2001)
103. Reginato, M.J., Krakow, S.L., Bailey, S.T., Lazar, M.A.: Prostaglandins promote and block
adipogenesis through opposing effects on peroxisome proliferator-activated receptor c.
J. Biol. Chem. 273, 1855-1858 (1998)
104. Burgermeister, E., Chuderland, D., Hanoch, T., Meyer, M., Liscovitch, M., Seger, R.:
Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-
activated receptor c. Mol. Cell. Biol. 27, 803-817 (2007)
105. Burgermeister, E., Seger, R.: MAPK kinases as nucleo-cytoplasmic shuttles for PPARc.
Cell Cycle 6, 1539-1548 (2007)
106. Hornberger, T.A., Armstrong, D.D., Koh, T.J., Burkholder, T.J., Esser, K.A.: Intracellular
signaling specificity in response to uniaxial versus multiaxial stretch: implications for
mechanotransduction. Am. J. Physiol. Cell Physiol. 288, C185-C194 (2005)
107. Vassaux, G., Gaillard, D., Ailhaud, G., Negrel, R.: Prostacyclin is a specific effector of
adipose cell differentiation. Its dual role as a cAMP- and Ca 2+ -elevating agent. J. Biol.
Chem. 267, 11092-11097 (1992)
108. Miller, C.W., Casimir, D.A., Ntambi, J.M.: The mechanism of inhibition of 3T3-L1
preadipocyte differentiation by prostaglandin F2a. Endocrinology 137, 5641-5650 (1996)
109. Tsuboi, H., Sugimoto, Y., Kainoh, T., Ichikawa, A.: Prostanoid EP4 receptor is involved in
suppression of 3T3-L1 adipocyte differentiation. Biochem. Biophys. Res. Commun. 322,
1066-1072 (2004)
110. Petersen, R.K., Jorgensen, C., Rustan, A.C., Froyland, L., Muller-Decker, K., Furstenberger,
G., Berge, R.K., Kristiansen, K., Madsen, L.: Arachidonic acid-dependent inhibition of
adipocyte differentiation requires PKA activity and is associated with sustained expression
of cyclooxygenases. J. Lipid Res. 44, 2320-2330 (2003)
111. Inazumi, T., Shirata, N., Morimoto, K., Takano, H., Segi-Nishida, E., Sugimoto, Y.:
Prostaglandin E2-EP4 signaling suppresses adipocyte differentiation in mouse embryonic
fibroblasts via an autocrine mechanism. J. Lipid Res. 52, 1500-1508 (2011)
112. Fain, J.N., Ballou, L.R., Bahouth, S.W.: Obesity is induced in mice heterozygous for
cyclooxygenase-2. Prostag. Other Lipid Mediat. 65, 199-209 (2001)
113. Amma, H., Naruse, K., Ishiguro, N., Sokabe, M.: Involvement of reactive oxygen species in
cyclic stretch-induced NF-jB activation in human fibroblast cells. Br. J. Pharmacol. 145,
364-373 (2005)
Search WWH ::




Custom Search